Gemin X is developing novel targeted therapies, including those that modulate apoptosis, to improve outcomes and quality of life for patients with cancer

Patients & Clinicians

Gemin X has multiple ongoing and planned clinical trials of its drug candidates across a broad range of cancer types as both a single agent and combination therapy.
>>more

Our Products

Gemin X is forging a new path for innovative therapeutics based on novel anti-cancer mechanisms such as: programmed cell death, or apoptosis, inducing cancer cell self-digestion, or autophagy, and the inhibition of metabolism in cancerous cells.
>>more

Upcoming Events